Accepted Preprint (first posted online 7 November 2016)

    Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways

    1. Morag Young
    1. G Ong, Cardiovascular Endocrinology Laboratory, Centre for Endocrinolgy and Metabolism, Hudson Institute of Medical Research, Clayton, Australia
    2. M Young, Cardiovascular Endocrinology Laboratory, Centre for Endocrinolgy and Metabolism, Hudson Institute of Medical Research, Clayton, Australia
    1. Correspondence: Morag Young, Email: morag.young{at}hudson.org.au

    Abstract

    The mineralocorticoid receptor (MR) and mineralocorticoids regulate epithelial handling of electrolytes, as well as inducing diverse effects on other organs. Traditionally, MR effects were ascribed to ligand-receptor binding and activation of gene transcription. However, the MR also utilises a number of intracellular signalling cascades, often by transactivating unrelated receptors, to more rapidly change cell function. Although aldosterone is the physiological mineralocorticoid, it is not the sole ligand for MR. Tissue-selective and mineralocorticoid specific effects are conferred through the enzyme 11β-hydroxysteroid dehydrogenase 2, cellular redox status and properties of the MR itself. Furthermore, not all aldosterone effects are mediated via MR, with implication of the involvement of other membrane bound receptors - such as GPER. This review will describe the ligands, receptors and intracellular mechanisms available for mineralocorticoid hormone and receptor signalling and illustrate their complex interactions in physiology and disease.

    • Received 29 April 2016
    • Revision received 17 October 2016
    • Accepted 6 November 2016
    • Accepted Preprint first posted online on 7 November 2016